160
Views
10
CrossRef citations to date
0
Altmetric
Review

Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?

, , , , &
Pages 2065-2079 | Published online: 04 Sep 2019

References

  • From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2018 Available from: http://www.goldcopd.org/. Accessed 731, 2009.
  • From the Global Strategy for the Diagnosis, Management and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD); 2017 Available from: https://goldcopd.org. Accessed 731, 2009.
  • Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Rev Esp Cardiol. 2016;69(2):177. doi:10.1016/j.recesp.2016.01.00226837729
  • Galie N, Humbert M, Vachiery JL, et al. 2015 ESC/ERS guidelines for the diagnosis and treatment of pulmonary hypertension: the joint task force for the diagnosis and treatment of pulmonary hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): endorsed by: association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J. 2016;37(1):67–119. doi:10.1093/eurheartj/ehv31726320113
  • Seeger W, Adir Y, Barbera JA, et al. Pulmonary hypertension in chronic lung diseases. J Am Coll Cardiol. 2013;62(25 Suppl):D109–D116. doi:10.1016/j.jacc.2013.10.03624355635
  • Barbera JA, Peinado VI, Santos S. Pulmonary hypertension in chronic obstructive pulmonary disease. Eur Respir J. 2003;21(5):892–905.12765440
  • Scharf SM, Iqbal M, Keller C, et al. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166(3):314–322. doi:10.1164/rccm.210702712153963
  • Chaouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32(5):1371–1385. doi:10.1183/09031936.0001560818978137
  • Blanco I, Piccari L, Barbera JA. Pulmonary vasculature in COPD: the silent component. Respirology. 2016;21(6):984–994. doi:10.1111/resp.1277227028849
  • Thabut G, Dauriat G, Stern JB, et al. Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation. Chest. 2005;127(5):1531–1536. doi:10.1378/chest.127.5.153115888824
  • Hoeper MM, Humbert M, Souza R, et al. A global view of pulmonary hypertension. Lancet Respir Med. 2016;4(4):306–322. doi:10.1016/S2213-2600(15)00543-326975810
  • Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(1):158–164. doi:10.1164/ajrccm.159.1.98031179872834
  • Weitzenblum E, Hirth C, Ducolone A, Mirhom R, Rasaholinjanahary J, Ehrhart M. Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease. Thorax. 1981;36(10):752–758. doi:10.1136/thx.36.10.7527330793
  • Cooper R, Ghali J, Simmons BE, Castaner A. Elevated pulmonary artery pressure. An independent predictor of mortality. Chest. 1991;99(1):112–120. doi:10.1378/chest.99.1.1121824624
  • Oswald-Mammosser M, Weitzenblum E, Quoix E, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107(5):1193–1198. doi:10.1378/chest.107.5.11937750305
  • Barbera JA, Blanco I. Management of pulmonary hypertension in patients with chronic lung disease. Curr Hypertens Rep. 2015;17(8):62. doi:10.1007/s11906-015-0574-926115628
  • Tanabe N, Taniguchi H, Tsujino I, et al. Multi-institutional retrospective cohort study of patients with severe pulmonary hypertension associated with respiratory diseases. Respirology. 2015;20(5):805–812. doi:10.1111/resp.1253025828844
  • Vitulo P, Stanziola A, Confalonieri M, et al. Sildenafil in severe pulmonary hypertension associated with chronic obstructive pulmonary disease: a randomized controlled multicenter clinical trial. J Heart Lung Transplant. 2017;36(2):166–174. doi:10.1016/j.healun.2016.04.01027329400
  • Andersen KH, Iversen M, Kjaergaard J, et al. Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease. J Heart Lung Transplant. 2012;31(4):373–380. doi:10.1016/j.healun.2011.11.02022226804
  • Tuder RM, Archer SL, Dorfmuller P, et al. Relevant issues in the pathology and pathobiology of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D4–D12. doi:10.1016/j.jacc.2013.10.02524355640
  • Chan AL, Juarez MM, Shelton DK, et al. Novel computed tomographic chest metrics to detect pulmonary hypertension. BMC Med Imaging. 2011;11:7. doi:10.1186/1471-2342-11-721447184
  • Hoeper MM, Lee SH, Voswinckel R, et al. Complications of right heart catheterization procedures in patients with pulmonary hypertension in experienced centers. J Am Coll Cardiol. 2006;48(12):2546–2552. doi:10.1016/j.jacc.2006.07.06117174196
  • Arcasoy SM, Christie JD, Ferrari VA, et al. Echocardiographic assessment of pulmonary hypertension in patients with advanced lung disease. Am J Respir Crit Care Med. 2003;167(5):735–740. doi:10.1164/rccm.200210-1130OC12480614
  • O’Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55(8):635–642. doi:10.1136/thorax.55.8.63510899238
  • Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. N Engl J Med. 2003;348(21):2059–2073. doi:10.1056/NEJMoa03028712759479
  • Klooster K, ten Hacken NH, Hartman JE, Kerstjens HA, van Rikxoort EM, Slebos DJ. Endobronchial valves for emphysema without interlobar collateral ventilation. N Engl J Med. 2015;373(24):2325–2335. doi:10.1056/NEJMoa150780726650153
  • Reilly J. Using computed tomographic scanning to advance understanding of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2006;3(5):450–455. doi:10.1513/pats.200604-101AW16799091
  • Leuraud K, Richardson DB, Cardis E, et al. Ionising radiation and risk of death from leukaemia and lymphoma in radiation-monitored workers (INWORKS): an international cohort study. Lancet Haematol. 2015;2(7):e276–e281. doi:10.1016/S2352-3026(15)00094-026436129
  • Dournes G, Verdier D, Montaudon M, et al. Dual-energy CT perfusion and angiography in chronic thromboembolic pulmonary hypertension: diagnostic accuracy and concordance with radionuclide scintigraphy. Eur Radiol. 2014;24(1):42–51. doi:10.1007/s00330-013-2975-y23982287
  • Dournes G, Grodzki D, Macey J, et al. Quiet submillimeter MR imaging of the lung is feasible with a PETRA Sequence at 1.5 T. Radiology. 2015;276(1):258–265. doi:10.1148/radiol.1514165525768672
  • Dournes G, Menut F, Macey J, et al. Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution. Eur Radiol. 2016;26(11):3811–3820. doi:10.1007/s00330-016-4218-526843010
  • Dournes G, Berger P, Refait J, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis: MR imaging of airway mucus contrasts as a tool for diagnosis. Radiology. 2017;285(1):261–269. doi:10.1148/radiol.201716235028530849
  • Dournes G, Yazbek J, Benhassen W, et al. 3D ultrashort echo time MRI of the lung using stack-of-spirals and spherical k-Space coverages: evaluation in healthy volunteers and parenchymal diseases. J Magn Reson Imaging. 2018;48(6):1489–1497. doi:10.1002/jmri.2621230203889
  • Benlala I, Berger P, Girodet PO, Dromer C, Macey J, Laurent F. Automated Volumetric Quantification of Emphysema Severity by Using Ultrashort Echo Time MRI: Validation in Participants with Chronic Obstructive Pulmonary Disease.. Radiology. 2019 Jul;292(1):216–225. doi:10.1148/radiol.2019190052 (in press).31161972
  • Vonk-Noordegraaf A, Haddad F, Chin KM, et al. Right heart adaptation to pulmonary arterial hypertension: physiology and pathobiology. J Am Coll Cardiol. 2013;62(25 Suppl):D22–D33. doi:10.1016/j.jacc.2013.10.02724355638
  • Reiter U, Reiter G, Fuchsjager M. MR phase-contrast imaging in pulmonary hypertension. Br J Radiol. 2016;89(1063):20150995. doi:10.1259/bjr.2015099526942293
  • Reichelt A, Hoeper MM, Galanski M, Keberle M. Chronic thromboembolic pulmonary hypertension: evaluation with 64-detector row CT versus digital substraction angiography. Eur J Radiol. 2009;71(1):49–54. doi:10.1016/j.ejrad.2008.03.01618462902
  • Tamura M, Yamada Y, Kawakami T, et al. Diagnostic accuracy of lung subtraction iodine mapping CT for the evaluation of pulmonary perfusion in patients with chronic thromboembolic pulmonary hypertension: correlation with perfusion SPECT/CT. Int J Cardiol. 2017;243:538–543. doi:10.1016/j.ijcard.2017.05.00628526539
  • Resten A, Maitre S, Capron F, Simonneau G, Musset D. [Pulmonary hypertension: CT findings in pulmonary veno-occlusive disease]. J Radiol. 2003;84(11 Pt 1):1739–1745.15022986
  • Mineo G, Attina D, Mughetti M, et al. Pulmonary veno-occlusive disease: the role of CT. Radiol Med. 2014;119(9):667–673. doi:10.1007/s11547-013-0363-y24297597
  • Rajaram S, Swift AJ, Condliffe R, et al. CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE registry. Thorax. 2015;70(4):382–387. doi:10.1136/thoraxjnl-2014-20608825523307
  • Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol. 2009;4:435–459. doi:10.1146/annurev.pathol.4.110807.09214518954287
  • Coxson HO, Dirksen A, Edwards LD, et al. The presence and progression of emphysema in COPD as determined by CT scanning and biomarker expression: a prospective analysis from the ECLIPSE study. Lancet Respir Med. 2013;1(2):129–136. doi:10.1016/S2213-2600(13)70006-724429093
  • Matsuoka S, Washko GR, Yamashiro T, et al. Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med. 2010;181(3):218–225. doi:10.1164/rccm.200908-1189OC19875683
  • Dournes G, Laurent F, Coste F, et al. Computed tomographic measurement of airway remodeling and emphysema in advanced chronic obstructive pulmonary disease. Correlation with pulmonary hypertension. Am J Respir Crit Care Med. 2015;191(1):63–70. doi:10.1164/rccm.201408-1423OC25393421
  • Bankier AA, De Maertelaer V, Keyzer C, Gevenois PA. Pulmonary emphysema: subjective visual grading versus objective quantification with macroscopic morphometry and thin-section CT densitometry. Radiology. 1999;211(3):851–858. doi:10.1148/radiology.211.3.r99jn0585110352615
  • Madani A, Zanen J, de Maertelaer V, Gevenois PA. Pulmonary emphysema: objective quantification at multi-detector row CT–comparison with macroscopic and microscopic morphometry. Radiology. 2006;238(3):1036–1043. doi:10.1148/radiol.238204219616424242
  • Di Stefano A, Turato G, Maestrelli P, et al. Airflow limitation in chronic bronchitis is associated with T-lymphocyte and macrophage infiltration of the bronchial mucosa. Am J Respir Crit Care Med. 1996;153(2):629–632. doi:10.1164/ajrccm.153.2.85641098564109
  • O’Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155(3):852–857. doi:10.1164/ajrccm.155.3.91170169117016
  • Saetta M. Airway inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(5 Pt 2):S17–S20. doi:10.1164/ajrccm.160.supplement_1.610556163
  • Burgel PR, Paillasseur JL, Peene B, et al. Two distinct chronic obstructive pulmonary disease (COPD) phenotypes are associated with high risk of mortality. PLoS One. 2012;7(12):e51048. doi:10.1371/journal.pone.005104823236428
  • Nakano Y, Wong JC, de Jong PA, et al. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med. 2005;171(2):142–146. doi:10.1164/rccm.200407-874OC15516531
  • Berger P, Perot V, Desbarats P, Tunon-de-Lara JM, Marthan R, Laurent F. Airway wall thickness in cigarette smokers: quantitative thin-section CT assessment. Radiology. 2005;235(3):1055–1064. doi:10.1148/radiol.235304012115833982
  • Montaudon M, Berger P, de Dietrich G, et al. Assessment of airways with three-dimensional quantitative thin-section CT: in vitro and in vivo validation. Radiology. 2007;242(2):563–572. doi:10.1148/radiol.242206002917179398
  • Meng Q, Kitasaka T, Nimura Y, Oda M, Ueno J, Mori K. Automatic segmentation of airway tree based on local intensity filter and machine learning technique in 3D chest CT volume. Int J Comput Assist Radiol Surg. 2017;12(2):245–261. doi:10.1007/s11548-016-1492-227796791
  • Lo P, van Ginneken B, Reinhardt JM, et al. Extraction of airways from CT (EXACT’09). IEEE Trans Med Imaging. 2012;31(11):2093–2107. doi:10.1109/TMI.2012.220967422855226
  • Aykac D, Hoffman EA, McLennan G, Reinhardt JM. Segmentation and analysis of the human airway tree from three-dimensional X-ray CT images. IEEE Trans Med Imaging. 2003;22(8):940–950. doi:10.1109/TMI.2003.81590512906248
  • Tschirren J, Hoffman EA, McLennan G, Sonka M. Intrathoracic airway trees: segmentation and airway morphology analysis from low-dose CT scans. IEEE Trans Med Imaging. 2005;24(12):1529–1539. doi:10.1109/TMI.2005.85765416353370
  • Lo P, Sporring J, Ashraf H, Pedersen JJ, de Bruijne M. Vessel-guided airway tree segmentation: a voxel classification approach. Med Image Anal. 2010;14(4):527–538. doi:10.1016/j.media.2010.03.00420395163
  • Patyk M, Obojski A, Gojny L, Panaszek B, Zaleska-Dorobisz U. Airway evaluation with multidetector computed tomography post-processing methods in asthmatic patients. Adv Exp Med Biol. 2016;934:41–47. doi:10.1007/5584_2016_2327271759
  • Monzon J, Liu L, Brill H, et al. CDKN2A mutations in multiple primary melanomas. N Engl J Med. 1998;338(13):879–887. doi:10.1056/NEJM1998032633813059516223
  • McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–1575. doi:10.1056/NEJMoa110695522029978
  • Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med. 1968;278(25):1355–1360. doi:10.1056/NEJM1968062027825015650164
  • Van Brabandt H, Cauberghs M, Verbeken E, Moerman P, Lauweryns JM, Van de Woestijne KP. Partitioning of pulmonary impedance in excised human and canine lungs. J Appl Physiol. 1983;55(6):1733–1742. doi:10.1152/jappl.1983.55.6.17336662764
  • Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol. 1992;72(3):1016–1023. doi:10.1152/jappl.1992.72.3.10161568955
  • Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–2653. doi:10.1056/NEJMoa03215815215480
  • Berger P, Laurent F, Begueret H, et al. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology. 2003;228(1):85–94. doi:10.1148/radiol.228102018712750458
  • Matsuoka S, Kurihara Y, Yagihashi K, Hoshino M, Watanabe N, Nakajima Y. Quantitative assessment of air trapping in chronic obstructive pulmonary disease using inspiratory and expiratory volumetric MDCT. AJR Am J Roentgenol. 2008;190(3):762–769. doi:10.2214/AJR.07.282018287450
  • Gruden JF, Webb WR, Warnock M. Centrilobular opacities in the lung on high-resolution CT: diagnostic considerations and pathologic correlation. AJR Am J Roentgenol. 1994;162(3):569–574. doi:10.2214/ajr.162.3.81094988109498
  • Xing AP, Hu XY, Shi YW, Du YC. Implication of PDGF signaling in cigarette smoke-induced pulmonary arterial hypertension in rat. Inhal Toxicol. 2012;24(8):468–475. doi:10.3109/08958378.2012.68888522746397
  • Peinado VI, Barbera JA, Ramirez J, et al. Endothelial dysfunction in pulmonary arteries of patients with mild COPD. Am J Physiol. 1998;274(6 Pt 1):L908–L913. doi:10.1152/ajplung.1998.274.6.L9089609729
  • Wrobel JP, McLean CA, Thompson BR, et al. Pulmonary arterial remodeling in chronic obstructive pulmonary disease is lobe dependent. Pulm Circ. 2013;3(3):665–674. doi:10.1086/67433924618551
  • Barbera JA, Peinado VI, Santos S, Ramirez J, Roca J, Rodriguez-Roisin R. Reduced expression of endothelial nitric oxide synthase in pulmonary arteries of smokers. Am J Respir Crit Care Med. 2001;164(4):709–713. doi:10.1164/ajrccm.164.4.210102311520741
  • Peinado VI, Barbera JA, Abate P, et al. Inflammatory reaction in pulmonary muscular arteries of patients with mild chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999;159(5 Pt 1):1605–1611. doi:10.1164/ajrccm.159.5.980705910228134
  • Yoshimura K, Suzuki Y, Uto T, Sato J, Imokawa S, Suda T. Morphological changes in small pulmonary vessels are associated with severe acute exacerbation in chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2016;11:1435–1445. doi:10.2147/COPD.S10742427418816
  • Matsuoka S, Yamashiro T, Diaz A, et al. The relationship between small pulmonary vascular alteration and aortic atherosclerosis in chronic obstructive pulmonary disease: quantitative CT analysis. Acad Radiol. 2011;18(1):40–46. doi:10.1016/j.acra.2010.08.01320947389
  • Estepar RS, Kinney GL, Black-Shinn JL, et al. Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. Am J Respir Crit Care Med. 2013;188(2):231–239. doi:10.1164/rccm.201301-0162OC23656466
  • Ma J, Yu N, Shen C, Wang Z, He T, Guo YM. A three-dimensional approach for identifying small pulmonary vessels in smokers. J Xray Sci Technol. 2017;25(3):391–402. doi:10.3233/XST-1621628157121
  • Ando K, Kuraishi H, Nagaoka T, et al. Potential role of CT metrics in chronic obstructive pulmonary disease with pulmonary hypertension. Lung. 2015;193(6):911–918. doi:10.1007/s00408-015-9813-826453478
  • Regan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. Copd. 2010;7(1):32–43. doi:10.3109/1541255090349952220214461
  • Mayo JR. CT evaluation of diffuse infiltrative lung disease: dose considerations and optimal technique. J Thorac Imaging. 2009;24(4):252–259. doi:10.1097/RTI.0b013e3181c227b219935222
  • Hackx M, Bankier AA, Gevenois PA. Chronic obstructive pulmonary disease: CT quantification of airways disease. Radiology. 2012;265(1):34–48. doi:10.1148/radiol.1211127022993219
  • Madani A, Van Muylem A, Gevenois PA. Pulmonary emphysema: effect of lung volume on objective quantification at thin-section CT. Radiology. 2010;257(1):260–268. doi:10.1148/radiol.1009144620663967
  • Madani A, De Maertelaer V, Zanen J, Gevenois PA. Pulmonary emphysema: radiation dose and section thickness at multidetector CT quantification–comparison with macroscopic and microscopic morphometry. Radiology. 2007;243(1):250–257. doi:10.1148/radiol.243106019417392257
  • Mets OM, Willemink MJ, de Kort FP, et al. The effect of iterative reconstruction on computed tomography assessment of emphysema, air trapping and airway dimensions. Eur Radiol. 2012;22(10):2103–2109. doi:10.1007/s00330-012-2489-z22618522
  • Coste F, Dournes G, Dromer C, et al. CT evaluation of small pulmonary vessels area in patients with COPD with severe pulmonary hypertension. Thorax. 2016;71(9):830–837. doi:10.1136/thoraxjnl-2015-20769627084957
  • Matsuoka S, Yamashiro T, Washko GR, Kurihara Y, Nakajima Y, Hatabu H. Quantitative CT assessment of chronic obstructive pulmonary disease. Radiographics. 2010;30(1):55–66. doi:10.1148/rg.30109511020083585
  • Gevenois PA, De Vuyst P, de Maertelaer V, et al. Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med. 1996;154(1):187–192. doi:10.1164/ajrccm.154.1.86806798680679
  • Grydeland TB, Dirksen A, Coxson HO, et al. Quantitative computed tomography measures of emphysema and airway wall thickness are related to respiratory symptoms. Am J Respir Crit Care Med. 2010;181(4):353–359. doi:10.1164/rccm.200907-1008OC19926869
  • Biernacki W, Gould GA, Whyte KF, Flenley DC. Pulmonary hemodynamics, gas exchange, and the severity of emphysema as assessed by quantitative CT scan in chronic bronchitis and emphysema. Am Rev Respir Dis. 1989;139(6):1509–1515. doi:10.1164/ajrccm/139.6.15092729756
  • Criner GJ, Scharf SM, Falk JA, et al. Effect of lung volume reduction surgery on resting pulmonary hemodynamics in severe emphysema. Am J Respir Crit Care Med. 2007;176(3):253–260. doi:10.1164/rccm.200608-1114OC17496227
  • Chaouat A, Savale L, Chouaid C, et al. Role for interleukin-6 in COPD-related pulmonary hypertension. Chest. 2009;136(3):678–687. doi:10.1378/chest.08-242019349390
  • Hurdman J, Condliffe R, Elliot CA, et al. Pulmonary hypertension in COPD: results from the ASPIRE registry. Eur Respir J. 2013;41(6):1292–1301. doi:10.1183/09031936.0007951223018917
  • Huang YS, Hsu HH, Chen JY, Tai MH, Jaw FS, Chang YC. Quantitative computed tomography of pulmonary emphysema and ventricular function in chronic obstructive pulmonary disease patients with pulmonary hypertension. Korean J Radiol. 2014;15(6):871–877. doi:10.3348/kjr.2014.15.6.87125469102
  • Madani A, Van Muylem A, de Maertelaer V, Zanen J, Gevenois PA. Pulmonary emphysema: size distribution of emphysematous spaces on multidetector CT images – comparison with macroscopic and microscopic morphometry. Radiology. 2008;248(3):1036–1041. doi:10.1148/radiol.248307143418710992
  • Diaz AA, Strand M, Coxson HO, et al. Disease severity dependence of the longitudinal association between CT lung density and lung function in smokers. Chest. 2018;153(3):638–645. doi:10.1016/j.chest.2017.10.01229066389
  • Johannessen A, Skorge TD, Bottai M, et al. Mortality by level of emphysema and airway wall thickness. Am J Respir Crit Care Med. 2013;187(6):602–608. doi:10.1164/rccm.201209-1722OC23328525
  • Ostridge K, Williams NP, Kim V, et al. Relationship of CT-quantified emphysema, small airways disease and bronchial wall dimensions with physiological, inflammatory and infective measures in COPD. Respir Res. 2018;19(1):31. doi:10.1186/s12931-018-0734-y29458372
  • Grydeland TB, Thorsen E, Dirksen A, et al. Quantitative CT measures of emphysema and airway wall thickness are related to D(L)CO. Respir Med. 2011;105(3):343–351. doi:10.1016/j.rmed.2010.10.01821074394
  • Nakano Y, Muro S, Sakai H, et al. Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med. 2000;162(3 Pt 1):1102–1108. doi:10.1164/ajrccm.162.3.990712010988137
  • Lee YK, Oh YM, Lee JH, et al. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung. 2008;186(3):157–165. doi:10.1007/s00408-008-9071-018351420
  • Coste F, Benlala I, Dournes G, et al. Quantitative CT assessment of bronchial and vascular alterations in severe precapillary pulmonary hypertension. Int J Chron Obstruct Pulmon Dis. 2019;14:381–389. doi:10.2147/COPD.S17763830809092
  • Han MK, Kazerooni EA, Lynch DA, et al. Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology. 2011;261(1):274–282. doi:10.1148/radiol.1111017321788524
  • Washko GR, Dransfield MT, Estepar RS, et al. Airway wall attenuation: a biomarker of airway disease in subjects with COPD. J Appl Physiol. 2009;107(1):185–191. doi:10.1152/japplphysiol.00216.200919407254
  • Burgel PR, Bourdin A, Chanez P, et al. Update on the roles of distal airways in COPD. Eur Respir Rev. 2011;20(119):7–22. doi:10.1183/09059180.1001061021357888
  • Galban CJ, Han MK, Boes JL, et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med. 2012;18(11):1711–1715. doi:10.1038/nm.297123042237
  • Iyer AS, Wells JM, Vishin S, Bhatt SP, Wille KM, Dransfield MT. CT scan-measured pulmonary artery to aorta ratio and echocardiography for detecting pulmonary hypertension in severe COPD. Chest. 2014;145(4):824–832. doi:10.1378/chest.13-142224114440
  • Iliaz S, Tanriverdio E, Chousein EGU, et al. Importance of pulmonary artery to ascending aorta ratio in chronic obstructive pulmonary disease. Clin Respir J. 2018;12(3):961–965. doi:10.1111/crj.1261228085229
  • Cuttica MJ, Bhatt SP, Rosenberg SR, et al. Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:1439–1446. doi:10.2147/COPD.S13141328553096
  • Ortac Ersoy E, Durusu Tanriover M, Ocal S, Gulsun Akpinar M, Topeli A. Measurement of pulmonary artery to aorta ratio in computed tomography is correlated with pulmonary artery pressure in critically ill chronic obstructive pulmonary disease patients. J Crit Care. 2016;33:42–46. doi:10.1016/j.jcrc.2016.01.02026936041
  • Wells JM, Washko GR, Han MK, et al. Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med. 2012;367(10):913–921. doi:10.1056/NEJMoa120383022938715
  • Compton GL, Florence J, MacDonald C, Yoo SJ, Humpl T, Manson D. Main pulmonary artery-to-ascending aorta diameter ratio in healthy children on MDCT. AJR Am J Roentgenol. 2015;205(6):1322–1325. doi:10.2214/AJR.15.1430126587940
  • Tan RT, Kuzo R, Goodman LR, Siegel R, Haasler GB, Presberg KW. Utility of CT scan evaluation for predicting pulmonary hypertension in patients with parenchymal lung disease. Medical college of wisconsin lung transplant group. Chest. 1998;113(5):1250–1256. doi:10.1378/chest.113.5.12509596302
  • Truong QA, Massaro JM, Rogers IS, et al. Reference values for normal pulmonary artery dimensions by noncontrast cardiac computed tomography: the Framingham Heart Study. Circ Cardiovasc Imaging. 2012;5(1):147–154. doi:10.1161/CIRCIMAGING.111.96861022178898
  • Shin S, King CS, Brown AW, et al. Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease. Respir Med. 2014;108(11):1626–1632. doi:10.1016/j.rmed.2014.08.00925225149
  • Mohamed Hoesein FA, Besselink T, Pompe E, et al. Accuracy of CT pulmonary artery diameter for pulmonary hypertension in end-stage COPD. Lung. 2016;194(5):813–819. doi:10.1007/s00408-016-9926-827423782
  • Wells JM, Morrison JB, Bhatt SP, Nath H, Dransfield MT. Pulmonary artery enlargement is associated with cardiac injury during severe exacerbations of COPD. Chest. 2016;149(5):1197–1204. doi:10.1378/chest.15-150426501747
  • Wells JM, Iyer AS, Rahaghi FN, et al. Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease. Circ Cardiovasc Imaging. 2015;8(4):e002546. doi:10.1161/CIRCIMAGING.114.00254625855668
  • Terzikhan N, Bos D, Lahousse L, et al. Pulmonary artery to aorta ratio and risk of all-cause mortality in the general population: the Rotterdam Study. Eur Respir J. 2017;49(6):1602168. doi:10.1183/13993003.02168-201628619955
  • Revel MP, Faivre JB, Remy-Jardin M, Delannoy-Deken V, Duhamel A, Remy J. Pulmonary hypertension: ECG-gated 64-section CT angiographic evaluation of new functional parameters as diagnostic criteria. Radiology. 2009;250(2):558–566. doi:10.1148/radiol.250208031519188324
  • Sanz J, Kariisa M, Dellegrottaglie S, et al. Evaluation of pulmonary artery stiffness in pulmonary hypertension with cardiac magnetic resonance. JACC Cardiovasc Imaging. 2009;2(3):286–295. doi:10.1016/j.jcmg.2008.08.00719356573
  • Ertan C, Tarakci N, Ozeke O, Demir AD. Pulmonary artery distensibility in chronic obstructive pulmonary disease. Echocardiography. 2013;30(8):940–944. doi:10.1111/echo.1217023489230
  • Pienn M, Kovacs G, Tscherner M, et al. Non-invasive determination of pulmonary hypertension with dynamic contrast-enhanced computed tomography: a pilot study. Eur Radiol. 2014;24(3):668–676. doi:10.1007/s00330-013-3067-824311231
  • Devaraj A, Wells AU, Meister MG, Corte TJ, Wort SJ, Hansell DM. Detection of pulmonary hypertension with multidetector CT and echocardiography alone and in combination. Radiology. 2010;254(2):609–616. doi:10.1148/radiol.0909054820093532
  • Simonneau G, Gatzoulis MA, Adatia I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2013;62(25 Suppl):D34–D41. doi:10.1016/j.jacc.2013.10.02924355639
  • Washko GR, Nardelli P, Ash SY, et al. Arterial vascular pruning, right ventricular size and clinical outcomes in COPD. Am J Respir Crit Care Med. 2019. doi:10.1164/rccm.201811-2063OC
  • Matsuoka S, Washko GR, Dransfield MT, et al. Quantitative CT measurement of cross-sectional area of small pulmonary vessel in COPD: correlations with emphysema and airflow limitation. Acad Radiol. 2010;17(1):93–99. doi:10.1016/j.acra.2009.07.02219796970
  • Uejima I, Matsuoka S, Yamashiro T, Yagihashi K, Kurihara Y, Nakajima Y. Quantitative computed tomographic measurement of a cross-sectional area of a small pulmonary vessel in nonsmokers without airflow limitation. Jpn J Radiol. 2011;29(4):251–255. doi:10.1007/s11604-010-0551-921607838
  • Park S, Lee SM, Kim N, Seo JB, Shin H. Automatic reconstruction of the arterial and venous trees on volumetric chest CT. Med Phys. 2013;40(7):071906. doi:10.1118/1.477196023822443
  • Iyer KS, Newell JD Jr, Jin D, et al. Quantitative dual-energy computed tomography supports a vascular etiology of smoking-induced inflammatory lung disease. Am J Respir Crit Care Med. 2016;193(6):652–661. doi:10.1164/rccm.201506-1196OC26569033
  • Payer C, Pienn M, Balint Z, et al. Automated integer programming based separation of arteries and veins from thoracic CT images. Med Image Anal. 2016;34:109–122. doi:10.1016/j.media.2016.05.00227189777
  • Charbonnier JP, Brink M, Ciompi F, Scholten ET, Schaefer-Prokop CM, van Rikxoort EM. Automatic pulmonary artery-vein separation and classification in computed tomography using tree partitioning and peripheral vessel matching. IEEE Trans Med Imaging. 2016;35(3):882–892. doi:10.1109/TMI.2015.250027926584489
  • Johns CS, Rajaram S, Capener DA, et al. Non-invasive methods for estimating mPAP in COPD using cardiovascular magnetic resonance imaging. Eur Radiol. 2018;28(4):1438–1448. doi:10.1007/s00330-017-5143-y29147768
  • Swift AJ, Rajaram S, Hurdman J, et al. Noninvasive estimation of PA pressure, flow, and resistance with CMR imaging: derivation and prospective validation study from the ASPIRE registry. JACC Cardiovasc Imaging. 2013;6(10):1036–1047. doi:10.1016/j.jcmg.2013.01.01323769494
  • Moral S, Fernandez-Friera L, Stevens G, et al. New index alpha improves detection of pulmonary hypertension in comparison with other cardiac magnetic resonance indices. Int J Cardiol. 2012;161(1):25–30. doi:10.1016/j.ijcard.2011.04.02421596452
  • Johns CS, Kiely DG, Rajaram S, et al. Diagnosis of pulmonary hypertension with cardiac MRI: derivation and validation of regression models. Radiology. 2019;290(1):61–68. doi:10.1148/radiol.201818060330351254